Literature DB >> 630326

Relapsing polychondritis with crescentic glomerulonephritis.

G H Neild, J S Cameron, M H Lessof, C S Ogg, D R Turner.   

Abstract

Relapsing polychondritis is rare and its cause is unknown. The tissues affected are those with a high glycosaminoglycan content, such as cartilage, the aorta, the sclera and cornea, and parts of the ear. Symptoms can usually be controlled with oral steroids, but when there is coexistent progressive crescentic glomerulonephritis quadruple chemotherapy may be used. Three cases of the clinical syndrome of relapsing polychondritis were studied in which rapidly progressive cresentic glomerulonephritis developed. In two the patients appeared to respond to aggressive treatment with immunosuppressive agents and anticoagulants. The multisystemic nature of the disease, the renal lesions, and the response to treatment all suggested that the condition might be related to periarteritis nodosa.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630326      PMCID: PMC1603302          DOI: 10.1136/bmj.1.6115.743

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Relapsing polychondritis. Analytical literature review and studies on pathogenesis.

Authors:  D L Dolan; G B Lemmon; S L Teitelbaum
Journal:  Am J Med       Date:  1966-08       Impact factor: 4.965

2.  Relapsing polychondritis. Three cases with a clinico-pathological study and literature review.

Authors:  R A Hughes; C L Berry; M Seifert; M H Lessof
Journal:  Q J Med       Date:  1972-07

3.  Circulating immunoglobulin complexes in Wegener's granulomatosis.

Authors:  S B Howell; W V Epstein
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

Review 4.  Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

Authors:  L P McAdam; M A O'Hanlan; R Bluestone; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

  4 in total
  11 in total

1.  Erosive arthritis in relapsing polychondritis.

Authors:  A S Jawad; M Burrel; K L Lim; D G Scott
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  Relapsing polychondritis: a review.

Authors:  Aman Sharma; Karthik Gnanapandithan; Kusum Sharma; Susmita Sharma
Journal:  Clin Rheumatol       Date:  2013-07-26       Impact factor: 2.980

3.  Relapsing polychondritis: relation to periarteritis nodosa.

Authors:  G Somers; P Potvliege
Journal:  Br Med J       Date:  1978-08-26

4.  Auricular chondritis and diffuse proliferative glomerulonephritis in primary Sjögren's syndrome.

Authors:  M A Rodriguez; F J Tapanes; I L Stekman; J A Pinto; O Camejo; I Abadi
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

5.  Relapsing polychondritis with severe aortic insufficiency.

Authors:  R Manna; V Annese; G Ghirlanda; F Pennestri; A V Greco; M A Pala; G B Bochicchio; M Magaro
Journal:  Clin Rheumatol       Date:  1985-12       Impact factor: 2.980

6.  Cryptogenic cirrhosis in relapsing polychondritis.

Authors:  N Islam; Z Ahmed; M N Alam
Journal:  Postgrad Med J       Date:  1983-04       Impact factor: 2.401

7.  Relapsing polychondritis with aortic arch aneurysm and aortic arch syndrome.

Authors:  M Giordano; G Valentini; A Sodano
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

8.  Epithelial crescent in diabetic glomeruli. A case report.

Authors:  T Tóth
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

9.  Ocular manifestations of relapsing polychondritis. Three case histories.

Authors:  H Brink; J Rademakers; A Verbeek; A van Ede; S Tilanus
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

10.  Patient Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis.

Authors:  Marcela A Ferrada; Peter C Grayson; Shubhasree Banerjee; Keith A Sikora; Robert A Colbert; Ninet Sinaii; James D Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-07-04       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.